Boston Scientific Discloses Cybersecurity Incident
Boston Scientific has disclosed a cybersecurity incident causing a global disruption to operations, including its ability to process and ship customer orders. The medical device maker filed an 8-K a day after detection on August 25, 2026, with shares falling approximately 3.5%.
The company has not identified the attacker or determined if the incident will have a material impact.
Key Takeaways:
- The incident involves a disruption to logistics rather than data, impacting hospital procedures scheduled with Boston Scientific devices.
- Standard incident response protocols were activated and third-party cybersecurity experts are involved.
- No ransom demand has been reported.
- Patient data privacy is not confirmed to be affected at this time.
Context:
This incident follows a trend of increasing cyberattacks on medical technology companies in 2026, with previous breaches involving Stryker, West Pharmaceutical Services, Abbott, iRhythm, Medtronic, Amgen, and Novo Nordisk.
The disclosure comes under new SEC requirements introduced in 2023 mandating reporting of material cybersecurity incidents within four business days.